$SKYE 4 SEC Filings

Filed On	Filing
24 Sep 2026	Form 4: Schwab Andrew J., Director Sold 28,700 shares ($47.4K) · Sold 119,379 shares ($192K)
24 Sep 2026	Form 4: 5AM Partners VII, Llc, 10% owner and 7 others Sold 28,700 shares ($47.4K) · Sold 119,379 shares ($192K)
18 Sep 2026	Form 4: Schwab Andrew J., Director Sold 33,892 shares ($64.7K)
18 Sep 2026	Form 4: 5AM Partners VII, Llc, 10% owner and 7 others Sold 33,892 shares ($64.7K)
20 Aug 2026	Form 4: Schwab Andrew J., Director Sold 300,000 shares ($114K) · Sold 68,140 shares ($23.8K) · Sold 7,700 shares ($2.46K)
20 Aug 2026	Form 4: 5AM Partners VII, Llc, 10% owner and 7 others Sold 300,000 shares ($114K) · Sold 68,140 shares ($23.8K) · Sold 7,700 shares ($2.46K)
07 Aug 2026	Form 4: Dhillon Punit, Director Received 1,090,000 shares as a grant or award
02 Apr 2026	Form 4: Smith Karen L., Director Granted 75,000 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Twitty Christopher, Chief Scientific Officer Granted 461,104 Stock Option (Right to Buy) · Disposed of 461,104 Stock Option (Right to Buy) (Disposition to Issuer)
02 Apr 2026	Form 4: Jenkins Annalisa, Director Granted 75,000 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Charych Deborah H., Director Granted 75,000 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Grayson Paul A., Director Granted 75,000 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Schwab Andrew J., Director Granted 75,000 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Diep Tuan Tu, Chief Operating Officer Granted 396,295 Stock Option (Right to Buy) · Disposed of 396,295 Stock Option (Right to Buy) (Disposition to Issuer)
02 Apr 2026	Form 4: Dhillon Punit, Director Granted 1,103,959 Stock Option (Right to Buy) · Disposed of 1,103,959 Stock Option (Right to Buy) (Disposition to Issuer)
09 Feb 2026	Form 4: Schwab Andrew J., Director Granted 35,000 Stock Option (Right to Buy)
09 Feb 2026	Form 4: Grayson Paul A., Director Granted 35,000 Stock Option (Right to Buy)
09 Feb 2026	Form 4: Smith Karen L., Director Granted 35,000 Stock Option (Right to Buy)
09 Feb 2026	Form 4: Arsenault Kaitlyn, Chief Financial Officer Granted 125,000 Stock Option (Right to Buy)
09 Feb 2026	Form 4: Twitty Christopher, Chief Scientific Officer Granted 150,000 Stock Option (Right to Buy)

Comments